LXU Fundamental Analysis - LSB INDUSTRIES INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to LXU. LXU was compared to 85 industry peers in the Chemicals industry. The financial health of LXU is average, but there are quite some concerns on its profitability. LXU has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year LXU was profitable.

LXU had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: LXU reported negative net income in multiple years.

Of the past 5 years LXU 4 years had a positive operating cash flow.

1.2 Ratios

LXU has a Return On Assets of -2.26%. This is in the lower half of the industry: LXU underperforms 68.24% of its industry peers.

LXU's Return On Equity of -5.43% is on the low side compared to the rest of the industry. LXU is outperformed by 67.06% of its industry peers.

		Industry Rank	Sector Rank
ROA	-2.26%
ROE	-5.43%
ROIC	N/A

ROA(3y)5.51%

ROA(5y)-2.47%

ROE(3y)15.37%

ROE(5y)-5.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of LXU has declined.

The Gross Margin of LXU (7.56%) is worse than 85.88% of its industry peers.

LXU's Gross Margin has improved in the last couple of years.

LXU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	7.56%

OM growth 3Y-59.74%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-28.46%

GM growth 5Y46.21%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LXU does not have a ROIC to compare to the WACC, probably because it is not profitable.

LXU has less shares outstanding than it did 1 year ago.

The number of shares outstanding for LXU has been increased compared to 5 years ago.

LXU has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.40, we must say that LXU is in the distress zone and has some risk of bankruptcy.

LXU's Altman-Z score of 1.40 is on the low side compared to the rest of the industry. LXU is outperformed by 69.41% of its industry peers.

A Debt/Equity ratio of 0.99 indicates that LXU is somewhat dependend on debt financing.

The Debt to Equity ratio of LXU (0.99) is worse than 67.06% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.99
Debt/FCF	N/A
Altman-Z	1.4

ROIC/WACCN/A

WACC8.93%

2.3 Liquidity

LXU has a Current Ratio of 2.51. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 2.51, LXU is in the better half of the industry, outperforming 70.59% of the companies in the same industry.

LXU has a Quick Ratio of 2.29. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.

LXU has a better Quick ratio (2.29) than 83.53% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.51
Quick Ratio	2.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

LXU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.67%, which is quite impressive.

Looking at the last year, LXU shows a decrease in Revenue. The Revenue has decreased by -4.23% in the last year.

Measured over the past years, LXU shows a small growth in Revenue. The Revenue has been growing by 7.43% on average per year.

EPS 1Y (TTM)56.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-69.23%

Revenue 1Y (TTM)-4.23%

Revenue growth 3Y-2.07%

Revenue growth 5Y7.43%

Sales Q2Q%3.78%

3.2 Future

Based on estimates for the next years, LXU will show a small growth in Earnings Per Share. The EPS will grow by 0.90% on average per year.

Based on estimates for the next years, LXU will show a small growth in Revenue. The Revenue will grow by 3.20% on average per year.

EPS Next Y-40.48%

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

EPS Next 5Y0.9%

Revenue Next Year10.02%

Revenue Next 2Y5.46%

Revenue Next 3Y5.98%

Revenue Next 5Y3.2%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.13, which indicates a rather expensive current valuation of LXU.

61.18% of the companies in the same industry are more expensive than LXU, based on the Price/Earnings ratio.

When comparing the Price/Earnings ratio of LXU to the average of the S&P500 Index (27.30), we can say LXU is valued slightly cheaper.

With a Price/Forward Earnings ratio of 80.34, LXU can be considered very expensive at the moment.

Based on the Price/Forward Earnings ratio, LXU is valued a bit more expensive than 70.59% of the companies in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, LXU is valued quite expensively.

		Industry Rank	Sector Rank
PE	18.13
Fwd PE	80.34

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LXU is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	10.29

4.3 Compensation for Growth

LXU's earnings are expected to decrease with -8.48% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for LXU!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

LSB INDUSTRIES INC

NYSE:LXU (7/11/2025, 8:04:00 PM)

After market: 8.52 0 (0%)

8.52

+0.16 (+1.91%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)04-29 2025-04-29/amc

Earnings (Next)07-23 2025-07-23/amc

Inst Owners54.39%

Inst Owner Change0%

Ins Owners4.22%

Ins Owner Change0.44%

Market Cap612.42M

Analysts77.5

Price Target8.39 (-1.53%)

Short Float %3.84%

Short Ratio3.85

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)102.45%

Min EPS beat(2)69.76%

Max EPS beat(2)135.15%

EPS beat(4)4

Avg EPS beat(4)103.34%

Min EPS beat(4)69.76%

Max EPS beat(4)135.15%

EPS beat(8)6

Avg EPS beat(8)43.21%

EPS beat(12)8

Avg EPS beat(12)22.5%

EPS beat(16)10

Avg EPS beat(16)37.33%

Revenue beat(2)2

Avg Revenue beat(2)9.9%

Min Revenue beat(2)6.25%

Max Revenue beat(2)13.55%

Revenue beat(4)3

Avg Revenue beat(4)6.5%

Min Revenue beat(4)-6.62%

Max Revenue beat(4)13.55%

Revenue beat(8)7

Avg Revenue beat(8)5.28%

Revenue beat(12)10

Avg Revenue beat(12)4.96%

Revenue beat(16)11

Avg Revenue beat(16)3.09%

PT rev (1m)-4.14%

PT rev (3m)-12.5%

EPS NQ rev (1m)0%

EPS NQ rev (3m)43.48%

EPS NY rev (1m)37.5%

EPS NY rev (3m)247.37%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)1.3%

Revenue NY rev (1m)0.62%

Revenue NY rev (3m)1.08%

Valuation

		Industry Rank	Sector Rank
PE	18.13
Fwd PE	80.34
P/S	1.16
P/FCF	N/A
P/OCF	8.84
P/B	1.25
P/tB	1.25
EV/EBITDA	10.29

EPS(TTM)0.47

EY5.52%

EPS(NY)0.11

Fwd EY1.24%

FCF(TTM)-0.36

FCFYN/A

OCF(TTM)0.96

OCFY11.32%

SpS7.34

BVpS6.82

TBVpS6.81

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.26%
ROE	-5.43%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	7.56%
FCFM	N/A

ROA(3y)5.51%

ROA(5y)-2.47%

ROE(3y)15.37%

ROE(5y)-5.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)9.64%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-59.74%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-28.46%

GM growth 5Y46.21%

F-Score4

Asset Turnover0.45

Health

		Industry Rank	Sector Rank
Debt/Equity	0.99
Debt/FCF	N/A
Debt/EBITDA	6.46
Cap/Depr	122.77%
Cap/Sales	17.98%
Interest Coverage	N/A
Cash Conversion	92.06%
Profit Quality	N/A
Current Ratio	2.51
Quick Ratio	2.29
Altman-Z	1.4

F-Score4

WACC8.93%

ROIC/WACCN/A

Cap/Depr(3y)96.58%

Cap/Depr(5y)76.59%

Cap/Sales(3y)11.38%

Cap/Sales(5y)9.83%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)56.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-69.23%

EPS Next Y-40.48%

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

EPS Next 5Y0.9%

Revenue 1Y (TTM)-4.23%

Revenue growth 3Y-2.07%

Revenue growth 5Y7.43%

Sales Q2Q%3.78%

Revenue Next Year10.02%

Revenue Next 2Y5.46%

Revenue Next 3Y5.98%

Revenue Next 5Y3.2%

EBIT growth 1Y-106.18%

EBIT growth 3Y-60.57%

EBIT growth 5YN/A

EBIT Next Year2094.57%

EBIT Next 3Y191.05%

EBIT Next 5Y92.67%

FCF growth 1Y-109.71%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-78.3%

OCF growth 3Y-0.4%

OCF growth 5Y110.4%

LSB INDUSTRIES INC (LXU) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens